11/14/2024
4:51 PM | Taysha Gene Therapies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
11/14/2024
8:40 AM | Avoro Capital Advisors LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
08/12/2024
7:32 AM | Taysha Gene Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:05 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
07/05/2024
4:49 PM | Porter Fred (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
4:50 PM | McAuliffe Sean (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
4:51 PM | McGinnis Emily (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
7:00 AM | Manning Paul B (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
4:12 PM | Taysha Gene Therapies (Filer)
| Form 424B5 | |
06/26/2024
4:14 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
5:14 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
5:07 AM | Taysha Gene Therapies (Filer)
| Form 424B5 | |
06/18/2024
6:45 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:18 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:19 PM | Taysha Gene Therapies (Filer)
| Form ARS | |
04/18/2024
3:21 PM | Taysha Gene Therapies (Filer)
| Form DEFA14A | |
03/19/2024
3:55 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
7:44 PM | Taysha Gene Therapies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
6:08 AM | RTW INVESTMENTS, LP (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
02/06/2024
3:42 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:06 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:41 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:42 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:43 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:20 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/20/2023
3:21 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:50 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:46 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:47 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
6:35 AM | Manning Paul B (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
